RICHARD MARTINEZ: Open Payments
NPI 1891213492 · SYLMAR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,630 in 93 payments from 9 companies in 2025. Trend: 2023 $611 · 2024 $1,069 · 2025 $2,630
Food & beverage: $2,511Education: $119
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 20 | $621 |
| Otsuka America Pharmaceutical, Inc. | 17 | $615 |
| Alkermes, Inc. | 17 | $397 |
| Teva Pharmaceuticals USA, Inc. | 11 | $259 |
| Lundbeck LLC | 16 | $201 |
| Janssen Pharmaceuticals, Inc | 3 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $151 |
| ViiV Healthcare Company | 5 | $144 |
| Merck Sharp & Dohme LLC | 2 | $52 |
Products named: COBENFY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, REXULTI, ARISTADA, INVEGA SUSTENNA, CAPLYTA, LYBALVI.
Industry payments across CA — which companies pay providers there.
